Home / Author Archives: bio972 (page 5)

Author Archives: bio972

Macrocure (NASDAQ:MCUR) Announces Second Quarter 2014 Results, Receives High Analysts’ Ratings מקרוקיור מדווח על תוצאות רבעון השניה 2014, מקבל דירוגים גבוהים מאנליסטים

Macrocure Ltd., a clinical-stage biotech company developing treatments for chronic and hard-to-heal wounds, recently announced second quarter financial results. Highlights noted in the fiscal summary include: In June, a meeting with the Data Safety Monitoring Board (DSMB) resulted in an advisement ...

Read More »